C12N 2501/90
Polysaccharides
C12N2501/90 (Polysaccharides) appears on 316 US grants and 604 published applications in this corpus.
Search patents in C12N- Granted patents
- 316
- Published applications
- 604
- Assignees
- 361
- Inventors
- 1,150
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 3 |
| 2002 | 5 | 8 |
| 2003 | 2 | 16 |
| 2004 | 2 | 6 |
| 2005 | 3 | 12 |
| 2006 | 11 | 17 |
| 2007 | 5 | 8 |
| 2008 | 3 | 12 |
| 2009 | 7 | 21 |
| 2010 | 7 | 18 |
| 2011 | 8 | 29 |
| 2012 | 15 | 21 |
| 2013 | 12 | 23 |
| 2014 | 9 | 15 |
| 2015 | 17 | 34 |
| 2016 | 20 | 38 |
| 2017 | 19 | 26 |
| 2018 | 17 | 32 |
| 2019 | 25 | 31 |
| 2020 | 15 | 40 |
| 2021 | 17 | 36 |
| 2022 | 16 | 32 |
| 2023 | 11 | 40 |
| 2024 | 15 | 29 |
| 2025 | 14 | 36 |
| 2026 | 15 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for the in vitro or ex vivo amplification of human adipose tissue stem cells1 Sep 2026US 12,723,234 B2Centre National de la Recherche Scientifique (CNRS)
- Method for producing cell aggregate1 Sep 2026US 12,723,236 B2Osaka University
- Methods for production of platelets from pluripotent stem cells and compositions thereof4 Aug 2026US RE50,977 E1Astellas Institute for Regenerative Medicine
- Method for enhancing secretory function of mesenchymal stem cells and application thereof21 Jul 2026US 12,686,854 B2Shandong University
- Methods for amplifying and differentiating pancreatic cells, and application thereof23 Jun 2026US 12,662,660 B2Shanghai Celliver Biotechnology Co., Ltd.
- Application of stem cells or transgenic stem cells8 Oct 2026US 2026/0306716 A1Anhui Longhui Stem Cell Biotechnology Co., Ltd
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells1 Oct 2026US 2026/0297516 A1
- Method of generating pancreatic beta cells17 Sep 2026US 2026/0275278 A1Bit Bio Limited
- Bioprinted Three-Dimensional Tumor Model17 Sep 2026US 2026/0275299 A1AdministracióN General Comunidad AutóNoma De Euskadi
- Repair and/or reconstruction of invertebral discs20 Aug 2026US 2026/0240918 A1Mesoblast, Inc.
Most cited
By later US patents
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002